S&P 500   5,093.48 (+0.47%)
DOW   39,010.20 (+0.16%)
QQQ   437.97 (+0.62%)
AAPL   181.45 (+0.02%)
MSFT   409.65 (+0.47%)
META   488.33 (+0.89%)
GOOGL   136.83 (+0.33%)
AMZN   172.93 (-0.13%)
TSLA   204.50 (+1.22%)
NVDA   787.62 (+1.42%)
NIO   5.57 (+2.58%)
AMD   178.89 (+1.33%)
BABA   74.63 (+0.05%)
T   17.01 (+0.29%)
F   12.42 (+0.98%)
MU   90.95 (+1.38%)
CGC   3.41 (+1.49%)
GE   156.09 (+0.31%)
DIS   111.44 (+0.58%)
AMC   4.60 (-7.82%)
PFE   27.11 (+0.26%)
PYPL   60.80 (+0.91%)
XOM   104.54 (+0.21%)
S&P 500   5,093.48 (+0.47%)
DOW   39,010.20 (+0.16%)
QQQ   437.97 (+0.62%)
AAPL   181.45 (+0.02%)
MSFT   409.65 (+0.47%)
META   488.33 (+0.89%)
GOOGL   136.83 (+0.33%)
AMZN   172.93 (-0.13%)
TSLA   204.50 (+1.22%)
NVDA   787.62 (+1.42%)
NIO   5.57 (+2.58%)
AMD   178.89 (+1.33%)
BABA   74.63 (+0.05%)
T   17.01 (+0.29%)
F   12.42 (+0.98%)
MU   90.95 (+1.38%)
CGC   3.41 (+1.49%)
GE   156.09 (+0.31%)
DIS   111.44 (+0.58%)
AMC   4.60 (-7.82%)
PFE   27.11 (+0.26%)
PYPL   60.80 (+0.91%)
XOM   104.54 (+0.21%)
S&P 500   5,093.48 (+0.47%)
DOW   39,010.20 (+0.16%)
QQQ   437.97 (+0.62%)
AAPL   181.45 (+0.02%)
MSFT   409.65 (+0.47%)
META   488.33 (+0.89%)
GOOGL   136.83 (+0.33%)
AMZN   172.93 (-0.13%)
TSLA   204.50 (+1.22%)
NVDA   787.62 (+1.42%)
NIO   5.57 (+2.58%)
AMD   178.89 (+1.33%)
BABA   74.63 (+0.05%)
T   17.01 (+0.29%)
F   12.42 (+0.98%)
MU   90.95 (+1.38%)
CGC   3.41 (+1.49%)
GE   156.09 (+0.31%)
DIS   111.44 (+0.58%)
AMC   4.60 (-7.82%)
PFE   27.11 (+0.26%)
PYPL   60.80 (+0.91%)
XOM   104.54 (+0.21%)
S&P 500   5,093.48 (+0.47%)
DOW   39,010.20 (+0.16%)
QQQ   437.97 (+0.62%)
AAPL   181.45 (+0.02%)
MSFT   409.65 (+0.47%)
META   488.33 (+0.89%)
GOOGL   136.83 (+0.33%)
AMZN   172.93 (-0.13%)
TSLA   204.50 (+1.22%)
NVDA   787.62 (+1.42%)
NIO   5.57 (+2.58%)
AMD   178.89 (+1.33%)
BABA   74.63 (+0.05%)
T   17.01 (+0.29%)
F   12.42 (+0.98%)
MU   90.95 (+1.38%)
CGC   3.41 (+1.49%)
GE   156.09 (+0.31%)
DIS   111.44 (+0.58%)
AMC   4.60 (-7.82%)
PFE   27.11 (+0.26%)
PYPL   60.80 (+0.91%)
XOM   104.54 (+0.21%)
NASDAQ:MMSI

Merit Medical Systems (MMSI) Stock Price, News & Analysis

$80.13
-0.35 (-0.43%)
(As of 02/28/2024 ET)
Today's Range
$79.34
$80.93
50-Day Range
$74.80
$81.25
52-Week Range
$62.58
$85.62
Volume
540,131 shs
Average Volume
362,085 shs
Market Capitalization
$4.63 billion
P/E Ratio
46.32
Dividend Yield
N/A
Price Target
$91.13

Merit Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
13.7% Upside
$91.13 Price Target
Short Interest
Healthy
3.86% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.16
Upright™ Environmental Score
News Sentiment
1.16mentions of Merit Medical Systems in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$1.60 M Sold Last Quarter
Proj. Earnings Growth
11.78%
From $2.97 to $3.32 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.83 out of 5 stars

Medical Sector

35th out of 958 stocks

Surgical & Medical Instruments Industry

9th out of 97 stocks


MMSI stock logo

About Merit Medical Systems Stock (NASDAQ:MMSI)

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Stock Price History

MMSI Stock News Headlines

Demystifying Merit Medical Systems: Insights From 5 Analyst Reviews
Q4 2023 Merit Medical Systems Inc Earnings Call
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
Merit Medical Systems: Q4 Earnings Insights
Rare Earth Elements: The Workhorse of The Tech Revolution
They're the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are.
MMSI Mar 2024 80.000 put
Merit Medical's (MMSI) SCOUT Guidance System Gets FDA Nod
Merit Medical Receives FDA 510(k) Clearance For SCOUT MD
Should You Buy Merit Medical (MMSI) After Golden Cross?
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/25/2023
Today
2/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
6,846
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$91.13
High Stock Price Target
$100.00
Low Stock Price Target
$81.00
Potential Upside/Downside
+13.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$74.52 million
Pretax Margin
9.03%

Debt

Sales & Book Value

Annual Sales
$1.15 billion
Cash Flow
$4.35 per share
Book Value
$20.11 per share

Miscellaneous

Free Float
55,613,000
Market Cap
$4.63 billion
Optionable
Optionable
Beta
0.91

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report














MMSI Stock Analysis - Frequently Asked Questions

Should I buy or sell Merit Medical Systems stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MMSI shares.
View MMSI analyst ratings
or view top-rated stocks.

What is Merit Medical Systems' stock price target for 2024?

7 analysts have issued 1-year target prices for Merit Medical Systems' shares. Their MMSI share price targets range from $81.00 to $100.00. On average, they expect the company's share price to reach $91.13 in the next twelve months. This suggests a possible upside of 13.7% from the stock's current price.
View analysts price targets for MMSI
or view top-rated stocks among Wall Street analysts.

How have MMSI shares performed in 2024?

Merit Medical Systems' stock was trading at $75.96 on January 1st, 2024. Since then, MMSI shares have increased by 5.5% and is now trading at $80.13.
View the best growth stocks for 2024 here
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) announced its earnings results on Tuesday, July, 25th. The medical instruments supplier reported $0.81 earnings per share for the quarter, topping analysts' consensus estimates of $0.75 by $0.06. The medical instruments supplier had revenue of $320.06 million for the quarter, compared to analyst estimates of $310.10 million. Merit Medical Systems had a trailing twelve-month return on equity of 14.71% and a net margin of 8.17%. Merit Medical Systems's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 EPS.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of 3.280-3.350 for the period, compared to the consensus earnings per share estimate of 3.320. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.92%), Conestoga Capital Advisors LLC (3.73%), Dimensional Fund Advisors LP (2.26%), Price T Rowe Associates Inc. MD (1.41%), Price T Rowe Associates Inc. MD (1.41%) and Westwood Holdings Group Inc. (1.30%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, F Ann Millner, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Michel James Voigt, Neil Peterson, Raul Jr Parra and Ronald Frost.
View institutional ownership trends
.

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Merit Medical Systems have any subsidiaries?
The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.
Read More
This page (NASDAQ:MMSI) was last updated on 2/29/2024 by MarketBeat.com Staff